United Therapeutics Stock Price History
| UTHR Stock | USD 313.70 0.10 0.03% |
Below is the normalized historical share price chart for United Therapeutics extending back to June 17, 1999. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of United Therapeutics stands at 313.70, as last reported on the 21st of March, with the highest price reaching 313.70 and the lowest price hitting 313.60 during the day.
If you're considering investing in United Stock, it is important to understand the factors that can impact its price. United Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.096, which indicates the firm had a -0.096 % return per unit of risk over the last 3 months. United Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate United Therapeutics' Variance of 5.49, coefficient of variation of (1,420), and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide.
At this time, United Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 03/21/2025, Common Stock Shares Outstanding is likely to grow to about 50.8 M, while Common Stock Total Equity is likely to drop slightly above 531.1 K. . At this time, United Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 03/21/2025, Price Earnings To Growth Ratio is likely to grow to 0.55, while Price Earnings Ratio is likely to drop 12.09. United Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of June 1999 | 200 Day MA 345.4484 | 50 Day MA 346.965 | Beta 0.639 |
United |
Sharpe Ratio = -0.096
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | UTHR |
Estimated Market Risk
| 2.29 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average United Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of United Therapeutics by adding United Therapeutics to a well-diversified portfolio.
Price Book 2.2223 | Enterprise Value Ebitda 6.8625 | Price Sales 4.8949 | Shares Float 41.3 M | Wall Street Target Price 396.4646 |
United Therapeutics Stock Price History Chart
There are several ways to analyze United Stock price data. The simplest method is using a basic United candlestick price chart, which shows United Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 19, 2025 | 380.78 |
| Lowest Price | March 11, 2025 | 304.42 |
United Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of United Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell United Stock. It can be used to describe the percentage change in the price of United Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of United Stock.| United Therapeutics Price Rate Of Daily Change | 1.00 | |
| United Therapeutics Price Daily Balance Of Power | 1.00 | |
| United Therapeutics Price Action Indicator | 0.10 |
United Therapeutics March 21, 2025 Stock Price Analysis
United Stock Price History Data
The price series of United Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 76.36 with a coefficient of variation of 6.42. The daily prices for the period are distributed with arithmetic mean of 350.59. The median price for the last 90 days is 359.58. The company experienced 2:1 stock split on 23rd of September 2009.| Open | High | Low | Close | Volume | ||
03/21/2025 | 313.60 | 313.69 | 313.60 | 313.69 | ||
03/21/2025 | 318.85 | 319.07 | 307.64 | 313.60 | ||
| 03/19/2025 | 315.17 | 319.07 | 307.64 | 318.85 | 539,286 | |
| 03/18/2025 | 322.32 | 324.57 | 313.98 | 314.12 | 417,950 | |
| 03/17/2025 | 307.86 | 324.22 | 304.55 | 322.94 | 400,603 | |
| 03/14/2025 | 305.06 | 310.17 | 305.06 | 307.24 | 494,807 | |
| 03/13/2025 | 306.88 | 307.98 | 299.47 | 305.39 | 444,224 | |
| 03/12/2025 | 304.22 | 307.73 | 301.25 | 307.09 | 723,345 | |
| 03/11/2025 | 314.74 | 318.06 | 303.62 | 304.42 | 553,500 | |
| 03/10/2025 | 313.93 | 323.99 | 313.93 | 317.87 | 436,075 | |
| 03/07/2025 | 307.15 | 320.81 | 306.11 | 315.91 | 740,107 | |
| 03/06/2025 | 309.06 | 311.87 | 305.00 | 307.68 | 423,068 | |
| 03/05/2025 | 307.40 | 312.86 | 306.49 | 310.98 | 479,480 | |
| 03/04/2025 | 308.09 | 315.53 | 305.33 | 308.59 | 649,344 | |
| 03/03/2025 | 316.46 | 320.76 | 307.92 | 310.03 | 640,527 | |
| 02/28/2025 | 324.06 | 324.06 | 313.66 | 320.05 | 657,486 | |
| 02/27/2025 | 318.80 | 326.74 | 315.07 | 323.62 | 997,173 | |
| 02/26/2025 | 343.53 | 344.81 | 307.38 | 318.89 | 1,699,396 | |
| 02/25/2025 | 362.42 | 364.98 | 351.08 | 357.50 | 591,259 | |
| 02/24/2025 | 361.35 | 365.22 | 358.17 | 358.21 | 874,860 | |
| 02/21/2025 | 366.60 | 369.00 | 355.85 | 361.10 | 407,154 | |
| 02/20/2025 | 377.29 | 378.52 | 362.50 | 367.36 | 633,038 | |
| 02/19/2025 | 373.15 | 383.51 | 371.94 | 380.78 | 564,844 | |
| 02/18/2025 | 370.00 | 374.35 | 366.00 | 372.83 | 431,904 | |
| 02/14/2025 | 370.93 | 370.93 | 364.62 | 370.58 | 209,345 | |
| 02/13/2025 | 369.00 | 372.69 | 365.00 | 370.44 | 302,067 | |
| 02/12/2025 | 352.61 | 370.89 | 350.24 | 370.74 | 626,644 | |
| 02/11/2025 | 348.05 | 363.00 | 346.49 | 353.31 | 508,279 | |
| 02/10/2025 | 351.24 | 351.24 | 345.22 | 345.64 | 347,824 | |
| 02/07/2025 | 355.76 | 357.00 | 344.39 | 347.71 | 291,371 | |
| 02/06/2025 | 355.93 | 356.57 | 351.29 | 353.75 | 466,441 | |
| 02/05/2025 | 348.21 | 358.87 | 348.21 | 354.18 | 386,195 | |
| 02/04/2025 | 353.10 | 355.78 | 348.52 | 353.43 | 312,065 | |
| 02/03/2025 | 348.17 | 358.63 | 344.36 | 354.58 | 369,022 | |
| 01/31/2025 | 355.18 | 357.31 | 350.02 | 351.17 | 414,604 | |
| 01/30/2025 | 370.00 | 370.40 | 349.07 | 352.30 | 500,892 | |
| 01/29/2025 | 373.00 | 378.52 | 370.20 | 372.75 | 169,580 | |
| 01/28/2025 | 370.99 | 382.61 | 368.02 | 370.85 | 320,223 | |
| 01/27/2025 | 369.82 | 375.35 | 368.52 | 369.56 | 246,082 | |
| 01/24/2025 | 372.73 | 375.61 | 365.88 | 370.83 | 198,583 | |
| 01/23/2025 | 372.55 | 374.15 | 367.02 | 371.89 | 243,375 | |
| 01/22/2025 | 371.37 | 373.88 | 366.20 | 371.28 | 318,242 | |
| 01/21/2025 | 361.00 | 369.85 | 360.46 | 367.97 | 655,365 | |
| 01/17/2025 | 372.34 | 372.34 | 357.25 | 358.93 | 248,351 | |
| 01/16/2025 | 362.74 | 369.71 | 362.74 | 366.39 | 255,042 | |
| 01/15/2025 | 369.52 | 370.48 | 360.36 | 361.64 | 303,094 | |
| 01/14/2025 | 361.97 | 366.48 | 357.55 | 364.70 | 294,962 | |
| 01/13/2025 | 366.64 | 368.36 | 361.06 | 362.88 | 277,055 | |
| 01/10/2025 | 362.94 | 365.33 | 358.80 | 364.97 | 264,858 | |
| 01/08/2025 | 363.99 | 367.41 | 360.00 | 366.61 | 252,791 | |
| 01/07/2025 | 355.94 | 362.98 | 355.81 | 362.33 | 190,720 | |
| 01/06/2025 | 355.70 | 358.67 | 351.05 | 355.39 | 268,152 | |
| 01/03/2025 | 360.92 | 364.19 | 355.87 | 356.33 | 235,306 | |
| 01/02/2025 | 352.33 | 360.97 | 350.93 | 360.22 | 287,499 | |
| 12/31/2024 | 359.34 | 360.30 | 352.24 | 352.84 | 266,921 | |
| 12/30/2024 | 358.00 | 361.44 | 352.56 | 357.64 | 268,434 | |
| 12/27/2024 | 362.22 | 364.60 | 357.31 | 359.96 | 133,589 | |
| 12/26/2024 | 360.70 | 365.02 | 360.20 | 364.10 | 220,963 | |
| 12/24/2024 | 363.46 | 364.48 | 360.87 | 360.87 | 138,361 | |
| 12/23/2024 | 359.59 | 364.95 | 356.00 | 363.65 | 237,998 | |
| 12/20/2024 | 359.50 | 363.90 | 357.99 | 359.58 | 1,009,463 |
About United Therapeutics Stock history
United Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for United is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in United Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing United Therapeutics stock prices may prove useful in developing a viable investing in United Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 48.5 M | 50.8 M | |
| Net Income Applicable To Common Shares | 836.4 M | 878.2 M |
United Therapeutics Quarterly Net Working Capital |
|
United Therapeutics Stock Technical Analysis
United Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
United Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for United Therapeutics' price direction in advance. Along with the technical and fundamental analysis of United Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of United to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | 0.0228 | |||
| Treynor Ratio | (0.40) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for United Stock Analysis
When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.